Despite the advent of advanced technologies—such as corneal stromal collagen crosslinking (CXL), intracorneal ring segments (ICRS), toric phakic and pseudophakic IOLs, and keratoplasty—patients with keratoconus are mostly being managed with spectacles and/or contact lenses.
Implant exchange in multifocal IOL recipients unhappy with their vision is better performed sooner rather than later. It is even better to avoid the exchange whenever possible by identifying and addressing a treatable cause for the patient’s complaints.
The best strategy of all is to prevent dissatisfaction in the first place by attention to patient selection and preoperative management, said Stephen G. Slade, MD.
In his debut blog, Dr. Packer writes of a cautionary tale to physicians when stuck between the wants and needs of married patients.
Highly variable myopia shifts can occur in pseudophakic children. IOL exchange seems to be an acceptable option for treating the high myopia that can develop with lens implantation in children.
However, the use of IOLs in growing eyes remains controversial, and outcomes are uncertain because of lack of data, according to Courtney Kraus, MD.
With a wide array of IOL options available to their foreign colleagues, U.S. ophthalmologists eagerly await the approval and availability of additional lenses.
A new intraocular mini-telescope is easy to implant through a small incision and has optimized optics so that it reliably provides good quality vision.
Alcon recently announced a partnership to in-license Google’s smart lens technology, but many questions remain. What will this new product bring to eye care and will it change ocular medicine?
Rayner Intraocular Lenses Ltd. have launched a new injector, RaySert Plus, in the United States market after receiving 510(k) clearance from the FDA.
The recent agreement between Valeant and Croma—which would provide for the distribution of Croma’s ophthalmology products in Western Europe—is expected to expand Bausch + Lomb’s (B + L) ophthalmic portfolio in the United States.